Next Article in Journal
Early Pharmacodynamic Changes Measured Using RNA Sequencing of Peripheral Blood from Patients in a Phase I Study with Mitazalimab, a Potent CD40 Agonistic Monoclonal Antibody
Next Article in Special Issue
Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS)
Previous Article in Journal
Mechanical Properties and Nanomotion of BT-20 and ZR-75 Breast Cancer Cells Studied by Atomic Force Microscopy and Optical Nanomotion Detection Method
Previous Article in Special Issue
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
 
 
Article

Article Versions Notes

Cells 2023, 12(19), 2364; https://doi.org/10.3390/cells12192364
Action Date Notes Link
article xml file uploaded 26 September 2023 15:39 CEST Original file -
article xml uploaded. 26 September 2023 15:39 CEST Update -
article pdf uploaded. 26 September 2023 15:39 CEST Version of Record https://www.mdpi.com/2073-4409/12/19/2364/pdf-vor
article html file updated 26 September 2023 15:41 CEST Original file -
article xml file uploaded 11 October 2023 10:06 CEST Update -
article xml uploaded. 11 October 2023 10:06 CEST Update https://www.mdpi.com/2073-4409/12/19/2364/xml
article pdf uploaded. 11 October 2023 10:06 CEST Updated version of record https://www.mdpi.com/2073-4409/12/19/2364/pdf
article html file updated 11 October 2023 10:08 CEST Update https://www.mdpi.com/2073-4409/12/19/2364/html
Back to TopTop